학술논문
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
Document Type
Academic Journal
Author
Source
The New England Journal of Medicine. March 23, 2006, Vol. 354 Issue 12, p1477, 12 p.
Subject
Language
English
ISSN
0028-4793
Abstract
Unfractioned heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardinal infarction thus a comparative study is conducted with a low-molecular-weight heparin, enoxaparin with unfractionated heparin. It is observed that in patients receiving fibrinolysis for ST-elevation myocardial infarction, treatment with enoxaparin throughout the index hospitalization is superior to treatment with unfractionated heparin for 48hours but is associated with an increase in major bleeding episodes.